Loading organizations...
Key people at LANXESS.
LANXESS is a specialty chemicals company, developing, manufacturing, and marketing chemical intermediates, additives, and consumer protection products. Its operations span Advanced Industrial Intermediates, Specialty Additives, and Consumer Protection segments, providing applications to diverse global markets. The company uses technical methods, including artificial intelligence, to optimize product development for its customers.
Established July 1, 2004, LANXESS originated from a corporate restructuring at Bayer AG. Bayer spun off its chemicals division and parts of its polymers business into an independent entity. This strategic decision created a focused enterprise dedicated to specialized chemical solutions, driven by an insight to streamline operations.
LANXESS serves a global customer base, prioritizing their needs to drive innovation. The company commits to sustainability, earning high environmental, social, and governance ratings. Its long-term vision delivers reliable, innovative product solutions, with a goal of achieving climate neutrality by 2040.
LANXESS has 1 tracked investment across 1 company. The latest tracked deal is $4.6M Series B in evocatal in June 2013.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 27, 2013 | evocatal | $4.6M Series B | — | Prof. Riesner, Roland Oetker, High Tech Grunderfonds, NRW.BANK, Sirius Venture Partners |
Key people at LANXESS.